 |
|
|
| |
Evaluation of lead HIV-1 vaccine regimen in APPROACH:
Phase 1/2a study testing heterologous prime boost regimens using mosaic Ad26 and MVA vectors combined with Env protein
|
| |
| |
Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
Hanneke Schuitemaker
VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.
Professor in Virology at the Academic Medical Center, University of Amsterdam
IAS | Paris, 24 July 2017
|
| |
|
|
|
|
|
